Premium
Degarelix lowers risk of sexual abuse in men with pedophilic disorder
Publication year - 2020
Publication title -
the brown university psychopharmacology update
Language(s) - English
Resource type - Journals
eISSN - 1556-7532
pISSN - 1068-5308
DOI - 10.1002/pu.30605
Subject(s) - medicine , sexual abuse , placebo , poison control , suicide prevention , medical emergency , alternative medicine , pathology
Men with pedophilic disorder who received injections of the gonadotropin‐releasing hormone (GnRH) antagonist degarelix acetate showed a significantly reduced risk score for committing child sexual abuse at 2 weeks, a placebo‐controlled trial has found. The results indicate potential for using GnRH antagonists as a rapidly acting preventive intervention for men with pedophilic disorder.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom